Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) EPS (Weighted Average and Diluted) (2016 - 2026)

Pediatrix Medical (MD) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $0.4 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 8.11% to $0.4 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.94 through Dec 2025, up 263.03% year-over-year, with the annual reading at $1.94 for FY2025, 263.03% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.4 at Pediatrix Medical, down from $0.84 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.84 in Q3 2025, with the low at -$1.84 in Q2 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.09, with a median of $0.3 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 1300.0% in 2021, then plummeted 641.18% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $0.29 in 2021, then increased by 6.9% to $0.31 in 2022, then crashed by 583.87% to -$1.5 in 2023, then surged by 124.67% to $0.37 in 2024, then increased by 8.11% to $0.4 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.4, $0.84, and $0.46 for Q4 2025, Q3 2025, and Q2 2025 respectively.